v3.25.1
FAIR VALUE MEASUREMENT - Narrative (Details)
$ / shares in Units, $ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Mar. 02, 2021
USD ($)
Mar. 31, 2025
USD ($)
shares
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2021
USD ($)
Mar. 31, 2025
$ / shares
Apr. 06, 2023
$ / shares
shares
Nov. 14, 2022
USD ($)
Nov. 14, 2022
CAD ($)
$ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Change in fair value of financial instruments   $ (126,000) $ (1,860,000)            
Investment in unconsolidated entity   10,700,000   $ 10,800,000          
Debt interest rate conversion feature   $ 970,000   $ 1,023,000          
Derivative Asset, Statement of Financial Position [Extensible Enumeration]   SBH purchase option and other derivative assets   SBH purchase option and other derivative assets          
Debt conversion option   $ 709,000   $ 786,000          
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]   Derivative and other long-term liabilities              
Purchase option $ 8,000,000       $ 8,000        
Purchase option, term         5 years        
Purchase option, extension term         2 years        
Percentage of outstanding shares         10.00%        
Warrants expiration period         60 days        
Loss on change in fair value of purchase option   $ 52,000 951,000            
Business combination, purchase option   0   52,000          
Debt Conversion Option                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Gain (loss) related to debt conversion   78,000 (56,000)            
Debt conversion option   709,000   786,000          
Level 3                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Investment in unconsolidated entity   10,700,000   10,800,000          
Debt interest rate conversion feature   970,000   1,023,000          
Debt conversion option   0   0          
Business combination, purchase option   0   52,000          
Debt Interest Rate Conversion Feature                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Gain (loss) related to debt conversion   (53,000) $ (54,000)            
BAT Group                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Convertible, ownership percentage of shares (as a percent)               19.90% 19.90%
Conversion price (in CAD per share) | $ / shares                 $ 2.00
BAT Group | Minimum                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Accrued interest rate, percentage               5.00% 5.00%
BAT Group | Maximum                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Accrued interest rate, percentage               1.50% 1.50%
BAT Group | Convertible Notes Payable                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Principal Amount   $ 58,812,000   58,172,000       $ 56,800,000 $ 75.3
Convertible, ownership percentage of shares (as a percent)   19.90%              
Conversion price (in CAD per share) | $ / shares           $ 2.00      
DeFloria, LLC                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Equity method ownership percentage   50.00%              
British American Tobacco | DeFloria, LLC                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Preferred units ownership percentage   100.00%              
AJNA Biosciences | DeFloria, LLC                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Equity method ownership percentage   50.00%              
DeFloria, LLC                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Warrants outstanding (in shares) | shares   4,000,000 400,000            
Stockholders' Equity Note, Stock Split, Conversion Ratio   0.1              
Change in fair value of financial instruments   $ (100,000) $ (800,000)            
Investment in unconsolidated entity   $ 10,700,000   10,800,000          
DeFloria, LLC | Common Class A                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares             865,052    
Warrants outstanding (in shares) | $ / shares             $ 2.89    
DeFloria, LLC | British American Tobacco                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Preferred units outstanding (in shares) | shares   2,000,000 200,000            
Capital contributed   $ 10,000,000              
Payment for convertible debt       5,000,000          
DeFloria, LLC | AJNA Biosciences                  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                  
Payment for convertible debt       $ 2,000,000          
Warrants outstanding (in shares) | shares   4,000,000 400,000